Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 3404 of 6351
-
Can a probiotic stop bloody diarrhea in kids faster?
Symptom relief OngoingAcute diarrhea (AD) is one of the commonest illnesses in children. A particularly severe form of diarrhea is bloody diarrhea (BD). Saccharomyces boulardii CNCM I-745 is a probiotic with demonstrated efficacy in children with acute diarrhea; however, evidence regarding its use in…
Phase 4 • Sponsor: Fundación Hospital de Pediatría Prof. Dr. Juan P. Garrahan • Aim: Symptom relief
Last updated Jun 27, 2026 09:00 UTC
-
Grape extract shows promise for easing fatigue in prostate cancer patients
Symptom relief CompletedIt is estimated that one-third of the more than 7 million deaths from cancer worldwide are attributable to potentially modifiable risk factors, with 374,000 deaths preventable through diet modification alone. Diet supplementation for the prevention or treatment of cancer is attra…
Phase 2 • Sponsor: Wake Forest University Health Sciences • Aim: Symptom relief
Last updated Jun 27, 2026 12:02 UTC
-
Unlocking the secrets of constipation: better tests on the horizon?
Knowledge-focused Recruiting nowResearchers are trying to better understand why constipation occurs and improve the tests for diagnosing these conditions.
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Aug 23, 2026 00:00 UTC
-
Leg workouts may boost walking in kids with cerebral palsy
Symptom relief OngoingThis is a randomized controlled trial, comparing 3 months of intensive leg exercise to standard physiotherapy care for the improvement of gross motor function in young children with spastic diplegia.
Sponsor: University of Alberta • Aim: Symptom relief
Last updated Jun 27, 2026 12:29 UTC
-
New drug duo shows promise for hard-to-treat cancers
Disease control CompletedThis phase Ib trial studies the side effects and best dose of ALRN-6924 when given together with paclitaxel in treating patients with solid tumors that have spread to other places in the body or cannot be removed by surgery. Drugs used in chemotherapy, such as ALRN-6924 and pacli…
Phase 1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
Exercise showdown: HIIT vs. moderate workouts for AFib patients
Symptom relief Recruiting nowThe main purpose of this project is to evaluate the effects of high-intensity interval training (HIIT) compared to moderate-intensity continuous exercise training (MICE) and standard care on exercise capacity and quality of life in patients with persistent or permanent atrial fib…
Sponsor: Ottawa Heart Institute Research Corporation • Aim: Symptom relief
Last updated Jun 27, 2026 11:00 UTC
-
Gene test before surgery could prevent drug reactions
Knowledge-focused Recruiting nowThe study is enrolling adults who are scheduled for either inpatient or outpatient elective surgical procedures at The University of Chicago. At pre-operative visits, patients will be consented and a blood sample will be obtained for preemptive genotyping across a panel of actio…
Sponsor: University of Chicago • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
New hope for rare tumors? drug axitinib tested in small trial
Disease control OngoingPrimary Objective: To determine the response rate (RR) of metastatic or locally advanced pheochromocytoma/paraganglioma to axitinib administered daily. Secondary Objectives: * Determine the progression-free survival. * In an exploratory manner examine the extent of activation …
Phase 2 • Sponsor: Columbia University • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Massive study aims to crack the code of metastatic breast cancer
Knowledge-focused Recruiting nowProspective multicenter observational study to assess molecular drivers of metastatic breast cancer and disease evolution upon therapeutic pressure. The main aim is to develop and validate prognostic, predictive and pathogenic markers in clinically well-characterized population-…
Sponsor: Lund University Hospital • Aim: Knowledge-focused
Last updated Jun 26, 2026 18:23 UTC
-
Custom DNA blood test could spot head and neck cancer return
Knowledge-focused CompletedLocally advanced head and neck squamous cell carcinoma (LAHNSCC) is a heterogeneous disease, associated with a poor prognosis and no improvement in overall survival for years. Furthermore, treatments (surgery, radiotherapy, chemotherapy) are frequently associated with acute and l…
Sponsor: Centre Henri Becquerel • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:08 UTC
-
New bone graft material could improve spine surgery outcomes
Disease control OngoingThis study aims to evaluate the performance and safety of the Orthoss® as a bone graft extender in lumbar spondylodesis involving 1-2 levels (L4-L5 and/or L5-S1).
Sponsor: Geistlich Pharma AG • Aim: Disease control
Last updated Jun 26, 2026 15:57 UTC
-
Family power: new study tests Parent-Led weight loss to fight cancer in african american communities
Disease control OngoingThis study tests the effectiveness of parent and family oriented support interventions that are designed to help with weight loss among African American families. Obesity tends to run in families, thus family based interventions, with parents as main change agents have been stron…
Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
Radioactive 'Smart Bomb' for tumours tested in early trial
Disease control Stopped earlyThis is a first-in-human Phase 1/2, non-randomized, multi-centre, open-label clinical study designed to investigate safety, tolerability, PK, and preliminary anti-tumour activity of \[225Ac\]-FPI-1434 (radioimmuno-therapeutic agent) in patients with solid tumours that demonstrate…
Phase 1 • Sponsor: Fusion Pharmaceuticals Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
Real-world nivolumab use in melanoma: what happens after surgery?
Knowledge-focused CompletedAn observational study of melanoma participants who are eligible for and who have initiated treatment with adjuvant nivolumab as part of routine clinical practice.
Sponsor: Bristol-Myers Squibb • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:01 UTC
-
Can acupuncture cool hot flashes in breast cancer survivors?
Symptom relief CompletedThis research study is evaluating acupuncture, a medical therapy in which hair-thin, stainless steel needles are shallowly inserted into specific points to help the body's natural healing process, as a possible treatment to reduce hot flashes.
Sponsor: Dana-Farber Cancer Institute • Aim: Symptom relief
Last updated Jun 27, 2026 11:00 UTC
-
Experimental drug zavesca tested for rare fatal brain diseases in infants
Disease control Stopped earlyGM2 gangliosidosis is an autosomal recessive subtype of Lysosomal Storage Diseases in which, Hexosaminidase A-B deficiency is caused by HEXA-B gene. HEXA deficiency is seen in Tay sachs and HEXB deficiency causes Sandhoff disease. Infantile forms of Sandhoff and Tay sachs are of…
Phase 3 • Sponsor: Tehran University of Medical Sciences • Aim: Disease control
Last updated Jun 26, 2026 17:51 UTC
-
New brain pacemaker programming shows promise for Parkinson's relief
Symptom relief CompletedThe study will explore the viability of an alternative/novel programming strategy in Deep Brain Stimulation (DBS) for patients with Parkinson's Disease (PD).
Sponsor: Boston Scientific Corporation • Aim: Symptom relief
Last updated Jun 27, 2026 08:03 UTC
-
Could a tiny zap to the head help stroke survivors speak again?
Symptom relief Recruiting nowThe purpose of this study is to determine whether the effect of treatment for acquired speech impairment can be enhanced by combining effective behavioral treatment with non-invasive brain stimulation. Transcranial direct current stimulation (tDCS), which delivers low-intensity c…
Sponsor: NYU Langone Health • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC
-
Could a natural hormone help hearts in pulmonary hypertension?
Disease control CompletedThe goal of this crossover trial is to determine whether the study drug dehydroepiandrosterone (DHEA) improves right ventricular longitudinal strain measured by cardiac magnetic resonance imaging at 18 weeks AND 40 weeks compared to placebo and to assess side effects and safety i…
Phase 2 • Sponsor: Rhode Island Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
New app could spot eye disease from your couch
Diagnosis By invitation onlyGroup 4a and 4b was an FDA trial that showed that patients who have an Amsler grid abnormality on paper, have a similar abnormality on the app. Group 7a and 7b was an FDA trial that showed that normal patients do not have false positives on the Amsler app as well as on the Amsle…
Sponsor: Neuro-Eye Diagnostic Systems, LLC • Aim: Diagnosis
Last updated Jun 27, 2026 12:06 UTC